Dosing for primary endpoint now completeLONDON, Sept. 19, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or...
Researchers at Cambridge say people who use cannabis are no more likely to lack motivation or be lazier than people ... Read More The post Weed...
Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely...
Psychedelics are being talked about at major conferences all over the world, including South by SouthWest and Aspen Institute's Ideas Week, signaling a...
Renowned academic journal praises company for development of psychoplastogens The post Delix gets recognized as leading start-up by Nature Biotechnology...
LONDON, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company...
As Oregon heads towards the first legal psilocybin system in the country, activists and educators come together to discuss the program ahead of next week's...
The Green Market Report honors the most innovative technology providers in the cannabis industry at its inaugural Tech Awards ceremony. The post The Green...
Ayahuasca's popularity is experiencing incredible growth - and creating a whole new tourism market in many communities. The post Meet Ayahuasca: A Breakout...
Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program The post Filament administers psilocybin...